Effects of Glucagon-Like Peptide-1 Analogs on Sexuality
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This placebo-controlled, double-blind crossover study is to evaluate the GLP-1 analogue
dulaglutide regarding changes in sexuality, the mood and the reproductive axis in healthy
men.
Phase:
Phase 2
Details
Lead Sponsor:
University Hospital, Basel, Switzerland
Collaborators:
Goldschmidt-Jacobson Foundation Swiss National Science Foundation